FDA approvals are significant milestones for companies in the healthcare and diagnostics sectors. This approval not only validates Labcorp's technology but also potentially opens up new revenue streams from the sales of the assay. Given the positive market perception of regulatory approvals, especially in the healthcare sector, this news is likely to have a favorable impact on Labcorp's stock price in the short term.